298 related articles for article (PubMed ID: 16847334)
1. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
Liu J; Wang H; Zuo Y; Farmer SR
Mol Cell Biol; 2006 Aug; 26(15):5827-37. PubMed ID: 16847334
[TBL] [Abstract][Full Text] [Related]
2. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
[TBL] [Abstract][Full Text] [Related]
3. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
Liu J; Farmer SR
J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
Handeli S; Simon JA
Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
[TBL] [Abstract][Full Text] [Related]
8. Regulation of PPARgamma activity during adipogenesis.
Farmer SR
Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S13-6. PubMed ID: 15711576
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
10. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
11. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
12. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.
Jansson EA; Are A; Greicius G; Kuo IC; Kelly D; Arulampalam V; Pettersson S
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1460-5. PubMed ID: 15665104
[TBL] [Abstract][Full Text] [Related]
13. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
Shimizu N; Kawakami K; Ishitani T
Dev Biol; 2012 Oct; 370(1):71-85. PubMed ID: 22842099
[TBL] [Abstract][Full Text] [Related]
14. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
Tutter AV; Fryer CJ; Jones KA
Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
[TBL] [Abstract][Full Text] [Related]
15. Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation.
Winer IS; Bommer GT; Gonik N; Fearon ER
J Biol Chem; 2006 Sep; 281(36):26181-7. PubMed ID: 16849322
[TBL] [Abstract][Full Text] [Related]
16. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
17. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
Williams BO; Barish GD; Klymkowsky MW; Varmus HE
Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]